Back
Delegates Premium Access

Boosting secondary prevention: efficacy and adherence of inclisiran in post-acute coronary syndrome very high-risk patients

Session: Supporting adherence: status quo and best practice
Topic: Treatment
Speaker: Doctor S. Sposini Ghezzi (Marsciano, IT)
Event: ESC Preventive Cardiology 2025

Congress Presentation

Add to my library

Like

About the speaker

Doctor Sara Sposini Ghezzi

Marsciano (Italy)
0 follower

4 more presentations in this session

Patient characteristics and discontinuation patterns amongst renin-angiotensin system inhibitor users in the United Kingdom: analysis using a national primary care database

Speaker: Miss Y. Yu (London, GB)

Access
Abstract
Slides
Like
Thumbnail

Structured pharmaceutical interviews enhance knowledge and medication adherence in DOAC therapy: EDUC-AOD, a case control study

Speaker: Doctor S. Cohen (Paris, FR)

Access
Abstract
Slides
Like
Thumbnail

Adherence to a lifestyle monitoring system in cardiac care: results of the Care-On clinical trial

Speaker: Ms M. Goevaerts (Eindhoven, NL)

Access
Abstract
Slides
Like
Thumbnail

Adherence to phase 3 cardiac rehabilitation: predictors and outcomes

Speaker: Professor R. Pinto (Lisbon, PT)

Access
Abstract
Slides
Like
Thumbnail

Access the full session

Supporting adherence: status quo and best practice

Speakers: Doctor S. Sposini Ghezzi, Miss Y. Yu, Doctor S. Cohen, Ms M. Goevaerts, Professor R. Pinto
Access
Like
Thumbnail

About the event

Image

ESC Preventive Cardiology 2025

3 April - 5 April 2025

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources